Homozygosis for (12) CA repeats in the first intron of the human IFN-γ gene is significantly associated with the risk of aplastic anaemia in Caucasian population

被引:52
作者
Dufour, C
Capasso, M
Svahn, J
Marrone, A
Haupt, R
Bacigalupo, A
Giordani, L
Longoni, D
Pillon, M
Pistorio, A
Di Michele, P
Iori, AP
Pongiglione, C
Lanciotti, M
Iolascon, A
机构
[1] G Gaslini Childrens Hosp, Dept Paediat Haematooncol, Haematol Unit, I-16147 Genoa, Italy
[2] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy
[3] CEINGE Adv Biotechnol, Naples, Italy
[4] G Gaslini Childrens Hosp, Sci Directorate, Epidemiol & Biostat Sect, Genoa, Italy
[5] Osped San Martino Genova, Dept Haematol, Genoa, Italy
[6] Univ Milan Bicocca, S Gerardo Hosp Monza, Dept Paediat, Milan, Italy
[7] Univ Padua, Dept Paediat, Haematol & Oncol Clin, I-35100 Padua, Italy
[8] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy
关键词
interferon-g polymorphisms; aplastic anaemia; Caucasian population;
D O I
10.1111/j.1365-2141.2004.05102.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interferon-gamma (IFN-gamma) mediates the final damage of the stem cell compartment in Aplastic Anaemia (AA). Normal subjects homozygous for 12 (CA) repeats of polymorphism variable number of dinucleotide (CA) repeat (VNDR) in position 1349 of the IFN-gamma gene (IFNG) were shown to overproduce IFN-gammain vitro. We studied the distribution of polymorphism VNDR 1349 of IFNG in 67 Caucasian AA patients and in normal controls. Genotype (CA)12-12, (homozygosis for allele 2) and the single allele 12 were significantly more frequent (P = 0.005 and 0.004 respectively) in patients versus controls. The polymorphism was equally distributed in AA patients regardless of their response to immunosuppression. Homozygosity for 12 (CA) repeats of polymorphism VNDR 1349 of IFNG is strongly associated with the risk of AA in Caucasian subjects.
引用
收藏
页码:682 / 685
页数:4
相关论文
共 10 条
[1]  
AWARD M, 1999, HUMAN IMMUNOLOGY, V60, P343
[2]   Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients [J].
Bacigalupo, A ;
Bruno, B ;
Saracco, P ;
Di Bona, E ;
Locasciulli, A ;
Locatelli, F ;
Gabbas, A ;
Dufour, C ;
Arcese, W ;
Testi, G ;
Broccia, G ;
Carotenuto, M ;
Coser, P ;
Barbui, T ;
Leoni, P ;
Ferster, A .
BLOOD, 2000, 95 (06) :1931-1934
[3]  
CAMITTA BM, 1976, BLOOD, V48, P63
[4]   Interferon γ and tumour necrosis factor α are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia [J].
Dufour, C ;
Corcione, A ;
Svahn, J ;
Haupt, R ;
Battilana, N ;
Pistoia, V .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) :1023-1031
[5]   Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia [J].
Frickhofen, N ;
Heimpel, H ;
Kaltwasser, JP ;
Schrezenmeier, H .
BLOOD, 2003, 101 (04) :1236-1242
[6]   HLA-DR TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) IN 2 HOURS - AN ALTERNATIVE TO SEROLOGICAL DR TYPING IN CLINICAL-PRACTICE INCLUDING DONOR-RECIPIENT MATCHING IN CADAVERIC TRANSPLANTATION [J].
OLERUP, O ;
ZETTERQUIST, H .
TISSUE ANTIGENS, 1992, 39 (05) :225-235
[7]   In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene [J].
Pravica, V ;
Asderakis, A ;
Perrey, C ;
Hajeer, A ;
Sinnott, PJ ;
Hutchinson, IV .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1999, 26 (01) :1-3
[8]   Allele frequencies of polymorphisms of the tumour necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 genes in a North European Caucasoid group from the UK [J].
Reynard, MP ;
Turner, D ;
Navarrete, CV .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 2000, 27 (04) :241-249
[9]   Antithymocyte globulin and cyclosporine for severe aplastic anemia - Association between hematologic response and long-term outcome [J].
Rosenfeld, S ;
Follmann, D ;
Nunez, O ;
Young, NS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (09) :1130-1135
[10]   Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia [J].
Young, NS .
SEMINARS IN HEMATOLOGY, 2000, 37 (01) :3-14